Ivabradine is indicated in the management of:
**Core Concept**
Ivabradine is a selective inhibitor of the I(f) channel, which is responsible for the funny current in the sinoatrial (SA) node. By inhibiting this channel, ivabradine reduces the heart rate without affecting contractility.
**Why the Correct Answer is Right**
Ivabradine works by blocking the I(f) channel, which leads to a decrease in the firing rate of the SA node. This results in a reduction in heart rate without affecting contractility or blood pressure. Ivabradine is particularly useful in patients with heart failure or coronary artery disease, where a reduction in heart rate can improve cardiac function and reduce symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** Ivabradine is not indicated for the treatment of hypertension. While reducing heart rate can lower blood pressure, ivabradine is not a primary treatment for hypertension.
**Option B:** Ivabradine is not a beta-blocker, so it does not have the same effects on contractility or vasodilation as beta-blockers like metoprolol.
**Option C:** Ivabradine is not indicated for the treatment of atrial fibrillation. While rate control is an important aspect of atrial fibrillation management, ivabradine is not a first-line treatment for this condition.
**Clinical Pearl / High-Yield Fact**
Ivabradine is a unique agent that targets the I(f) channel, making it a useful addition to the treatment armamentarium for heart failure and coronary artery disease. Its mechanism of action is distinct from beta-blockers and other rate-limiting agents.
**Correct Answer:** C. Heart failure or coronary artery disease.